Epilepsia · 2014 · 21 citations · 7 references
Veterinary MedicineInfectious DiseasesNeuroscienceInnate ImmunityNeuroimmunologyParasite ImmunologyComplement SystemComplement-mediated InjuryInnate Immune Responses To ParasitesInnate Immunity To ParasitesMalariaNeurological Parasitic DiseasesCerebral MalariaCerebral Malaria-associated SeizuresComplement In Disease PathogenesisMembrane Attack ComplexNeurocognitive DeficitsSeizuresTerminal Complement ComplexTerminal Complement Pathway Inhibition
Studies have demonstrated that the membrane attack complex (MAC) of complement can evoke seizures when injected directly into rodent brain. In the course of studies that examine the role of complement in the development of experimental cerebral malaria (ECM), we observed fewer seizures in mice deficient in C5, a component required for MAC formation. To determine if the MAC contributed to the tonic-clonic seizures characteristic of ECM, we performed long-term video-electroencephalography (EEG) on C5(-/-) mice with Plasmodium berghei ANKA-induced cerebral malaria and observed significantly reduced spike and seizure frequency compared to wild-type mice. Our data suggest a role for the MAC in malaria-induced seizures and that inhibition of the terminal complement pathway may reduce seizures and seizure-related neurocognitive deficits.
7
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
Peter Hillmen, Neal S. Young, Jörg Schubert et al. · New England Journal of Medicine · 2006 · 1.3K citations · Full text
Medicine, Hematology, Pharmacology +17
C5 deficiency and C5a or C5aR blockade protects against cerebral malaria
Samir N. Patel, Joanne Berghout, Fiona Lovegrove et al. · The Journal of Experimental Medicine · 2008 · 102 citations · Full text
Life Sciences, Genetics, Immunology +16